NCT07143604 - A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 29, 2025

Primary Completion Date

September 28, 2026

Study Completion Date

September 28, 2027

Conditions

Gastric CancerGastroesophageal Junction Cancer

Interventions

DRUG

AZD0901

Participants will receive AZD0901 IV, Q3W

Trial Locations (13)

111123

RECRUITING

Research Site, Moscow

115478

RECRUITING

Research Site, Moscow

115533

RECRUITING

Research Site, Moscow

125284

RECRUITING

Research Site, Moscow

142770

RECRUITING

Research Site, Moscow

143423

RECRUITING

Research Site, Moscow

194291

RECRUITING

Research Site, Saint Petersburg

197022

RECRUITING

Research Site, Saint Petersburg

197758

RECRUITING

Research Site, Saint Petersburg

454092

RECRUITING

Research Site, Chelyabinsk

603126

RECRUITING

Research Site, Nizhny Novgorod

630108

NOT_YET_RECRUITING

Research Site, Novosibirsk

Unk

RECRUITING

Research Site, Volgograd